NEW YORK (GenomeWeb News) — GeneNews today said it will pocket $2 million as part of a deal to develop and validate biomarkers for prostate diseases, including cancer, for an unnamed Asian biomedical consortium.
 
GeneNews said it will use its Sentinel Principle and Discovery Funnel technologies to find the biomarkers. If a biomarker panel is successfully validated, GeneNews will develop and market a blood-based diagnostic called ProstateSentry.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.